読み込み中
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
終値時点
$23.33
+$0.58 · +2.55%
時間外
$23.33
$0.00 · 0.00%
10月9日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
日中レンジ
現在 $23.33
52週レンジ
現在 $23.33
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
39
割高
センチメント
61
強気
リスク
44
やや高いリスク
モメンタム
63
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
日中レンジ
現在 $23.33
52週レンジ
現在 $23.33
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 研究開発 | 6348.9万 USD | 4136.4万 USD | 3696.6万 USD | 2565.4万 USD | 1097.7万 USD |
| 販売・一般管理 | 2054.7万 USD | 1665.1万 USD | 768.2万 USD | 717.6万 USD | 463.3万 USD |
| 営業費用 | 8403.6万 USD | 5801.5万 USD | 4464.8万 USD | 3283万 USD | 1561万 USD |
| 受取利息 | 1129.7万 USD | 426.1万 USD | 58.1万 USD | 14.9万 USD | — |
| 支払利息 | 6.3万 USD | 10.7万 USD | 15.2万 USD | 14.4万 USD | 22.4万 USD |
| 減価償却費と償却費 | 137.5万 USD | 164.5万 USD | 147.8万 USD | 100.6万 USD | 36.4万 USD |
| 営業利益 | −8403.6万 USD | −5801.5万 USD | −4464.8万 USD | −3283万 USD | −1561万 USD |
| 純利益 | −7415.1万 USD | −5798.2万 USD | −4282.3万 USD | −3218万 USD | −892.7万 USD |
会社概要が更新されました 2026年10月10日.
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Russell 2000 ETFIWM625.35万0.01%781.81億 USD0.19%$278.94+0.49%
iShares Russell 2000 Value ETFIWN187.85万0.01%138.33億 USD0.24%$210.87-0.04%
Vanguard Russell 2000 ETFVTWO176.52万0.01%180億 USD0.06%$112.66+0.50%
iShares Biotechnology ETFIBB166.22万0.02%102.68億 USD0.44%$206.49+3.00%
iShares Micro-Cap ETFIWC78.63万0.06%13.16億 USD0.60%$183+0.11%
Vanguard Health Care ETFVHT77.07万0.00%220億 USD0.09%$319.01+1.64%
ALPS Medical Breakthroughs ETFSBIO56.45万0.30%1.87億 USD0.50%$55.04+2.03%
Avantis U.S. Small Cap Equity ETFAVSC49.9万0.02%30.61億 USD0.25%$69.98+0.03%iShares Russell 2000 ETFIWMiShares Russell 2000 Value ETFIWNVanguard Russell 2000 ETFVTWOiShares Biotechnology ETFIBBiShares Micro-Cap ETFIWCVanguard Health Care ETFVHTALPS Medical Breakthroughs ETFSBIOAvantis U.S. Small Cap Equity ETFAVSCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
